Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1

AIDS Research and Human Retroviruses

Volumn 13, Issue 9, 1997, Pages 789-796

  Buckheit R W , Jr ^a   Hollingshead, M ^a   Stinson, S ^a   Fliakas Boltz, V ^a   Pallansch, L A ^a   Roberson, J ^a   Decker, W ^a   Elder, C ^a   Borgel, S ^a   Bonomi, C ^a   Shores, R ^a   Siford, T ^a   Malspeis, L ^a   Bader, J P ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS ISOLATION;

EID: 18544400158     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.789     Document Type: Article

References (29)